BIOC Biocept (BIOC) revenue drops 23% in Q2; loss narrows 6 years ago Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company’s revenue declined by 23% year-over-year… Biocept (BIOC) – Is it worth buying? 6 years ago Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we… Biocept Inc. (NASDAQ: BIOC) Q1 2020 Earnings Call Transcript 6 years ago Biocept Inc. (BIOC) Q1 2020 earnings call dated May 13, 2020 Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and… Biocept (BIOC) posts wider-than-expected loss in Q4 6 years ago Biocept, Inc. (NASDAQ: BIOC) reported a narrower loss in the fourth quarter of 2019 driven by higher revenue. The bottom… « Previous